BNP Paribas Financial Markets’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $120K | Sell |
28,385
-17,258
| -38% | -$66.5K | ﹤0.01% | 4462 |
|
|
2026
Q1 | $160K | Buy |
45,643
+13,189
| +41% | +$54.1K | ﹤0.01% | 4146 |
|
|
2025
Q4 | $109K | Sell |
32,454
-1,877
| -5% | -$4.87K | ﹤0.01% | 4336 |
|
|
2025
Q3 | $45K | Buy |
34,331
+15,594
| +83% | +$16.1K | ﹤0.01% | 4640 |
|
|
2025
Q2 | $13.4K | Sell |
18,737
-355,662
| -95% | -$279K | ﹤0.01% | 4763 |
|
|
2025
Q1 | $550K | Buy |
374,399
+251,759
| +205% | +$600K | ﹤0.01% | 3135 |
|
|
2024
Q4 | $543K | Sell |
122,640
-32,020
| -21% | -$130K | ﹤0.01% | 3243 |
|
|
2024
Q3 | $637K | Buy |
154,660
+72,815
| +89% | +$391K | ﹤0.01% | 2744 |
|
|
2024
Q2 | $534K | Sell |
81,845
-530,755
| -87% | -$3.75M | ﹤0.01% | 2633 |
|
|
2024
Q1 | $5.34M | Buy |
612,600
+39,653
| +7% | +$481K | ﹤0.01% | 1419 |
|
|
2023
Q4 | $6.55M | Buy |
572,947
+148,402
| +35% | +$1.47M | 0.01% | 1249 |
|
|
2023
Q3 | $4.09M | Sell |
424,545
-13,943
| -3% | -$137K | 0.01% | 1411 |
|
|
2023
Q2 | $4.67M | Buy |
438,488
+87,725
| +25% | +$943K | 0.01% | 1272 |
|
|
2023
Q1 | $3.69M | Buy |
350,763
+211,818
| +152% | +$2.37M | 0.01% | 1429 |
|
|
2022
Q4 | $1.72M | Sell |
138,945
-447,827
| -76% | -$5.08M | ﹤0.01% | 1844 |
|
|
2022
Q3 | $6.08M | Buy |
586,772
+547,982
| +1,413% | +$6.21M | 0.01% | 1263 |
|
|
2022
Q2 | $447K | Buy |
38,790
+24,513
| +172% | +$289K | ﹤0.01% | 2716 |
|
|
2022
Q1 | $180K | Sell |
14,277
-19,272
| -57% | -$221K | ﹤0.01% | 3168 |
|
|
2021
Q4 | $391K | Buy |
33,549
+1,256
| +4% | +$15.4K | ﹤0.01% | 3126 |
|
|
2021
Q3 | $422K | Buy |
32,293
+18,007
| +126% | +$233K | ﹤0.01% | 2810 |
|
|
2021
Q2 | $184K | Sell |
14,286
-320,956
| -96% | -$3.67M | ﹤0.01% | 2887 |
|
|
2021
Q1 | $3.75M | Buy |
335,242
+314,035
| +1,481% | +$3.32M | 0.01% | 1336 |
|
|
2020
Q4 | $242K | Sell |
21,207
-16,874
| -44% | -$185K | ﹤0.01% | 2788 |
|
|
2020
Q3 | $343K | Buy |
38,081
+15,322
| +67% | +$152K | ﹤0.01% | 2440 |
|
|
2020
Q2 | $235K | Sell |
22,759
-52,919
| -70% | -$542K | ﹤0.01% | 2430 |
|
|
2020
Q1 | $764K | Buy |
75,678
+53,546
| +242% | +$629K | ﹤0.01% | 2108 |
|
|
2019
Q4 | $295K | Sell |
22,132
-5,470
| -20% | -$60.3K | ﹤0.01% | 2781 |
|
|
2019
Q3 | $237K | Buy |
27,602
+8,676
| +46% | +$84.3K | ﹤0.01% | 2664 |
|
|
2019
Q2 | $207K | Sell |
18,926
-20,018
| -51% | -$224K | ﹤0.01% | 2604 |
|
|
2019
Q1 | $441K | Buy |
38,944
+35,034
| +896% | +$391K | ﹤0.01% | 2173 |
|
|
2018
Q4 | $33.9K | Sell |
3,910
-5,512
| -59% | -$63.3K | ﹤0.01% | 2902 |
|
|
2018
Q3 | $146K | Buy |
9,422
+771
| +9% | +$12.2K | ﹤0.01% | 2553 |
|
|
2018
Q2 | $139K | Sell |
8,651
-25,889
| -75% | -$383K | ﹤0.01% | 2621 |
|
|
2018
Q1 | $446K | Buy |
34,540
+1,432
| +4% | +$17.8K | ﹤0.01% | 2290 |
|
|
2017
Q4 | $416K | Buy |
33,108
+13,826
| +72% | +$181K | ﹤0.01% | 2581 |
|
|
2017
Q3 | $255K | Sell |
19,282
-1,071
| -5% | -$14.7K | ﹤0.01% | 2343 |
|
|
2017
Q2 | $322K | Buy |
20,353
+17,243
| +554% | +$251K | ﹤0.01% | 2155 |
|
|
2017
Q1 | $44.4K | Sell |
3,110
-2,042
| -40% | -$27.9K | ﹤0.01% | 2779 |
|
|
2016
Q4 | $66K | Sell |
5,152
-7,704
| -60% | -$97.3K | ﹤0.01% | 2707 |
|
|
2016
Q3 | $171K | Buy |
12,856
+6,855
| +114% | +$80.1K | ﹤0.01% | 1828 |
|
|
2016
Q2 | $65.7K | Buy |
+6,001
| New | +$58.6K | ﹤0.01% | 2239 |
|
|
2016
Q1 | – | Sell |
-30,762
| Closed | -$299K | – | 2872 |
|
|
2015
Q4 | $299K | Sell |
30,762
-329
| -1% | -$3.18K | ﹤0.01% | 1671 |
|
|
2015
Q3 | $271K | Buy |
31,091
+18,581
| +149% | +$173K | ﹤0.01% | 1748 |
|
|
2015
Q2 | $126K | Buy |
12,510
+9,118
| +269% | +$106K | ﹤0.01% | 1964 |
|
|
2015
Q1 | $45.5K | Buy |
+3,392
| New | +$44.5K | ﹤0.01% | 1966 |
|
|
2014
Q4 | – | Sell |
-8,393
| Closed | -$91.1K | – | 2581 |
|
|
2014
Q3 | $91.1K | Buy |
8,393
+8,109
| +2,855% | +$92.8K | ﹤0.01% | 2240 |
|
|
2014
Q2 | $3.65K | Buy |
284
+185
| +187% | +$2.01K | ﹤0.01% | 2769 |
|
|
2014
Q1 | $915 | Sell |
99
-1,342
| -93% | -$15.1K | ﹤0.01% | 2888 |
|
|
2013
Q4 | $14K | Sell |
1,441
-29,373
| -95% | -$264K | ﹤0.01% | 2427 |
|
|
2013
Q3 | $306K | Sell |
30,814
-8,774
| -22% | -$86.1K | ﹤0.01% | 1904 |
|
|
2013
Q2 | $330K | Buy |
+39,588
| New | +$480K | ﹤0.01% | 1914 |
|
Other funds holding IRWD
AC
BNP Paribas Financial Markets's IRWD Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Ironwood Pharmaceuticals (IRWD) stake by 38% in Q2 2026, selling an estimated $66.5K and leaving 28,385 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #4462.
BNP Paribas Financial Markets first reported a position in IRWD in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.55M in Q4 2023. 202 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.
- BNP Paribas Financial Markets held 28,385 shares of Ironwood Pharmaceuticals worth $120K as of Q2 2026.
- BNP Paribas Financial Markets sold 17,258 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $66.5K.
- Ironwood Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4462 holding.
- BNP Paribas Financial Markets first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- BNP Paribas Financial Markets's Ironwood Pharmaceuticals position peaked at $6.55M in Q4 2023.
- 202 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.